SCHEMBL2404221

SCHEMBL2404221

COC(=O)c1[nH]c(C(C)C)cc1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
GAA P10253 4/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
PADI4 Q9UM07 1/20 0.35
MAPT P10636 2/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12271224 0.87 HCAR3 (0.33) GAAKDM4EHTTCA12CA1
SCHEMBL2403427 0.79 HCAR3 (0.43) HCAR3HCAR2
SCHEMBL2405027 0.79 NPC1 (0.48) CYP1A2ALDH1A1KDM4EHTTMAPT
SCHEMBL10308264 0.78 MAPK14 (0.49) CYP1A2GAAALDH1A1KDM4EHPGD
SCHEMBL13456131 0.77 CYP1A2 (0.36) CYP1A2GAAALDH1A1KDM4ENPSR1
SCHEMBL257678 0.73 GABRA1 (0.48) CYP1A2GAAALDH1A1KDM4ENPSR1
SCHEMBL10717495 0.71 MAPT (0.49) CYP1A2GAAALDH1A1KDM4EMAPT
SCHEMBL26924264 0.70 PDE4A (0.31) CYP1A2ALDH1A1HPGDHSD17B10MEN1
SCHEMBL2586738 0.70 CYP1A2 (0.46) CYP1A2GAAALDH1A1KDM4EMAPT
SCHEMBL257667 0.69 CNR2 (0.41) GAAALDH1A1KDM4ENPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722730-B2 5-membered heterocyclic compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2014-05-13 US disclosed
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
EP-2189445-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUND Research Foundation Itsuu Laboratory (JP) 2010-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213156-A1 5-MEMBERED HETEROCYCLIC COMPOUND RXRA, RXRG, RXRB CYP1A2 150/4885GAA 3182/4885ALDH1A1 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.